- List
- By Topic
- On Map
- Search Details

Recruiting, Not yet recruiting, Available Studies | "Adverse Drug Events" OR "Adverse Drug Reactions" OR "Drug Related Side Effects"
Need help? See RSS Feeds
Choose a feed type:

Recruiting, Not yet recruiting, Available Studies | "Adverse Drug Events" OR "Adverse Drug Reactions" OR "Drug Related Side Effects" (168 records)
Need help? See Downloading Content for Analysis
For Advanced Users: Full Study Record XML Download
1 | NCT03442010 | Recruiting | Adverse Drug Events at Emergency Department |
|
|
Observational |
|
Other |
|
|
13453 | All | 18 Years and older (Adult, Senior) | NCT03442010 | RECHMPL18_0095 | ADEsED | November 1, 2011 | November 1, 2018 | May 1, 2019 | February 22, 2018 | February 22, 2018 |
|
||
2 | NCT03272607 | Recruiting | Reducing Post-discharge Adverse Drug Events Amongst the Elderly: a Multi-centre Electronic Deprescribing Intervention |
|
|
Interventional | Not Applicable |
|
Other |
|
|
8400 | All | 65 Years and older (Adult, Senior) | NCT03272607 | MedSafer CIHR Application No. 365795 |
August 22, 2017 | July 2019 | October 2019 | September 5, 2017 | September 5, 2017 |
|
||
3 | NCT03093818 | Recruiting | PREemptive Pharmacogenomic Testing for Preventing Adverse Drug REactions |
|
|
Interventional | Not Applicable |
|
Other |
|
|
8100 | All | 18 Years and older (Adult, Senior) | NCT03093818 | 668353 (U-PGx) | PREPARE | March 20, 2017 | December 2019 | December 2019 | March 28, 2017 | April 18, 2017 |
|
|
4 | NCT02059044 | Recruiting | Information Systems-enabled Outreach Program for Adverse Drug Events |
|
|
Interventional | Not Applicable |
|
Other |
|
|
2200 | All | 18 Years and older (Adult, Senior) | NCT02059044 | 20130285 MOP125975 |
ISTOP-ADE | October 2015 | June 2019 | January 2020 | February 11, 2014 | February 1, 2018 |
|
|
5 | NCT03176342 | Recruiting | Drug Patch Tests in Patients With Severe Cutaneous Adverse Reaction to Drugs (SCARs) |
|
|
Interventional | Not Applicable |
|
Other |
|
|
30 | All | 18 Years and older (Adult, Senior) | NCT03176342 | 204/59 | August 4, 2016 | August 3, 2017 | August 3, 2017 | June 5, 2017 | June 6, 2017 |
|
||
6 | NCT03156348 | Recruiting | Impact of Clinical Pharmacist on Adverse Drug Events in Older Adults |
|
|
Interventional | Not Applicable |
|
Other |
|
|
611 | All | 60 Years and older (Adult, Senior) | NCT03156348 | SA14ID0141 | May 2, 2015 | September 22, 2017 | December 22, 2017 | May 17, 2017 | May 17, 2017 |
|
||
7 | NCT00414115 | Recruiting | National Active Surveillance Network and Pharmacogenomics of Adverse Drug Reactions in Children |
|
Observational |
|
Other / Industry |
|
|
7000 | All | Child, Adult, Senior | NCT00414115 | H04-70358 CW Health Centre of BC W04-0138 |
August 2005 | July 2019 | July 2019 | December 21, 2006 | November 6, 2017 |
|
||||
8 | NCT02906657 | Recruiting | Medication Reconciliation Using Electronic Pharmaceutical Record: A Multicenter Study in the Hospitalized Elderly |
|
|
Interventional | Not Applicable |
|
Other |
|
|
2000 | All | 60 Years and older (Adult, Senior) | NCT02906657 | K14101 | CONCIPAGE | November 2016 | November 2018 | December 2018 | September 20, 2016 | May 3, 2017 |
|
|
9 | NCT03475589 | Recruiting New |
Study on the Adverse Drug Reactions (ADRs) of Apatinib and Their Biomarker Correlations |
|
|
Interventional | Phase 4 |
|
Other |
|
|
217 | All | 18 Years and older (Adult, Senior) | NCT03475589 | A2018-002 | March 2018 | December 2019 | December 2019 | March 23, 2018 | March 23, 2018 |
|
||
10 | NCT02297126 | Recruiting | A Prospective Trial to Assess Cost and Clinical Outcomes of a Clinical Pharmacogenomic Program |
|
|
Interventional | Not Applicable |
|
Other / NIH |
|
|
6000 | All | 18 Years and older (Adult, Senior) | NCT02297126 | 1401206188 U01HG007762-01 |
INGenious | January 2015 | June 2018 | June 2018 | November 21, 2014 | November 20, 2017 |
|
|
11 | NCT03369509 | Recruiting | Allergic Versus Non Allergic Hypersensitivity Drug Reaction (BdDAllergo) |
|
Observational |
|
Other |
|
|
1200 | All | 18 Years and older (Adult, Senior) | NCT03369509 | 38RC17.038 2017-A00378-45 |
BdDAllergo | May 29, 2017 | May 28, 2022 | May 28, 2022 | December 12, 2017 | December 12, 2017 |
|
|||
12 | NCT03383133 | Not yet recruiting | Studies of Sulfur Metabolism in Humans |
|
|
Interventional | Early Phase 1 |
|
Other |
|
|
1 | Male | 61 Years to 61 Years (Adult) | NCT03383133 | 2017-8685 | January 2018 | March 2018 | April 2018 | December 26, 2017 | December 27, 2017 | |||
13 | NCT02374840 | Not yet recruiting | Pharmacogenomics Registry to Assess Clinical Utility |
|
Observational |
|
Industry |
|
|
340778 | All | 2 Years and older (Child, Adult, Senior) | NCT02374840 | CD-2014-102 | PREACT | February 2019 | March 2, 2015 | July 22, 2015 | ||||||
14 | NCT03042286 | Recruiting | SAPhIRE Statin Adverse Drug Reaction |
|
Observational |
|
Other |
|
|
1500 | All | 21 Years to 99 Years (Adult, Senior) | NCT03042286 | 2014/00856 | STATIN | March 2015 | May 2017 | May 2017 | February 3, 2017 | February 3, 2017 |
|
|||
15 | NCT03259399 | Recruiting | A Pharmacogenomics Study of Enalapril-Induced Adverse Drug Reaction |
|
|
Observational |
|
Other |
|
|
2200 | All | 18 Years and older (Adult, Senior) | NCT03259399 | 2016[1238] | August 16, 2017 | December 2017 | December 2018 | August 23, 2017 | August 24, 2017 |
|
|||
16 | NCT03261908 | Not yet recruiting | A Pharmacogenomics Study of Simvastatin-Induced Adverse Drug Reaction |
|
|
Observational |
|
Other |
|
|
2200 | All | 18 Years and older (Adult, Senior) | NCT03261908 | 2016[1237] | August 2017 | December 2017 | December 2018 | August 25, 2017 | August 25, 2017 |
|
|||
17 | NCT03312647 | Recruiting | Adverse Drug Reactions to Anti-TB Drugs in the Treatment of Latent Tuberculosis Infection |
|
Observational |
|
Other |
|
|
1000 | All | 19 Years and older (Adult, Senior) | NCT03312647 | HYUMC_CM_002 | June 19, 2017 | May 2018 | May 2018 | October 18, 2017 | October 18, 2017 |
|
||||
18 | NCT02520570 | Recruiting | Post-market Safety Reassessment of Ulinastatin for Injection |
|
|
Observational |
|
Industry / Other |
|
|
10000 | All | Child, Adult, Senior | NCT02520570 | 002/20140709 | August 2014 | June 2018 | July 2018 | August 13, 2015 | January 17, 2018 |
|
|||
19 | NCT02036957 | Recruiting | MARY DUOL REPAIR BALM IN THE PREVENTION OR REDUCING ANTINEOPLASIC AGENTS' SKIN TOXICITY |
|
|
Interventional | Phase 1 Phase 2 |
|
Other |
|
|
86 | Female | Child, Adult, Senior | NCT02036957 | MD-01 | B-DUOL | February 2014 | June 2017 | June 2017 | January 15, 2014 | August 2, 2016 |
|
|
20 | NCT03270839 | Recruiting | Motion Sickness Medications and Vestibular Time Constant |
|
|
Interventional | Phase 4 |
|
Other |
|
|
80 | Male | 18 Years to 40 Years (Adult) | NCT03270839 | 1723-2016 | June 1, 2017 | March 1, 2018 | May 1, 2018 | September 1, 2017 | September 1, 2017 |
|
||
21 | NCT03296930 | Not yet recruiting | Effect Of DAAs For Treatment Of HCV On Normal Kidney |
|
|
Interventional | Phase 4 |
|
Other |
|
|
100 | All | 18 Years to 70 Years (Adult, Senior) | NCT03296930 | DAAs on Normal Kidney | October 1, 2017 | September 30, 2018 | October 31, 2018 | September 29, 2017 | September 29, 2017 | |||
22 | NCT01715584 | Recruiting | Is There an Adverse Drug Reaction Between Renin-Angiotensin System Blockade and Inhaled Anesthetics |
|
|
Interventional | Phase 4 |
|
Other |
|
|
80 | All | 40 Years and older (Adult, Senior) | NCT01715584 | 5982 | July 2012 | December 31, 2019 | December 31, 2019 | October 29, 2012 | August 23, 2017 |
|
||
23 | NCT03492242 | Recruiting New |
Immune CHeckpoint Inhibitors Monitoring of Adverse Drug ReAction |
|
|
Observational |
|
Other |
|
|
1000 | All | 18 Years and older (Adult, Senior) | NCT03492242 | CIC1421-18-06 | CHIMeRA | February 1, 2018 | May 1, 2018 | May 1, 2018 | April 10, 2018 | April 11, 2018 |
|
||
24 | NCT03166241 | Not yet recruiting | Serum Interleukin -21 Level in Patients With Severe Adverse Cutaneous Drug Reaction. |
|
|
Interventional | Not Applicable |
|
Other |
|
|
30 | All | Child, Adult, Senior | NCT03166241 | ACDR | July 2017 | July 2018 | December 2018 | May 25, 2017 | May 25, 2017 | |||
25 | NCT03029897 | Recruiting | E-reporting of Adverse Drug Reactions by Patients in Relapsing-remitting Multiple Sclerosis |
|
|
Interventional | Not Applicable |
|
Other |
|
|
160 | All | 18 Years and older (Adult, Senior) | NCT03029897 | 16-135 | VigiP-SEP | May 5, 2017 | July 2018 | October 2018 | January 24, 2017 | January 25, 2018 |
|
|
26 | NCT03420469 | Not yet recruiting | Bupropion Stereoselective Disposition and CYP2D6-mediated Drug Interactions in Healthy Volunteers |
|
|
Interventional | Not Applicable |
|
Other / NIH |
|
|
29 | All | 18 Years to 55 Years (Adult) | NCT03420469 | 1R01GM121707-01A1 | June 1, 2018 | May 1, 2020 | May 1, 2020 | February 2, 2018 | March 14, 2018 | |||
27 | NCT03212365 | Recruiting | Minimization of Bleeding Related Adverse Drug Events in Plastic & Reconstructive Surgery |
|
|
Interventional | Phase 2 |
|
Other |
|
|
270 | All | 18 Years and older (Adult, Senior) | NCT03212365 | 100416 | July 3, 2017 | June 30, 2019 | September 30, 2019 | July 11, 2017 | August 16, 2017 |
|
||
28 | NCT03177174 | Recruiting | Different Chemotherapy Protocols Combined With Intensity Modulated Radiation Therapy in Patients With Locally Advanced Nasopharyngeal Carcinoma |
|
|
Interventional | Not Applicable |
|
Other |
|
|
150 | All | 18 Years to 70 Years (Adult, Senior) | NCT03177174 | S2017-030-02 | June 12, 2017 | May 31, 2020 | June 1, 2020 | June 6, 2017 | June 27, 2017 |
|
||
29 | NCT02609919 | Recruiting | Assessment of Immediate Adverse Reactions From Dotarem in Children Under 2 Years of Age |
|
|
Observational |
|
Other |
|
|
200 | All | up to 2 Years (Child) | NCT02609919 | Dotarem Study 26250 |
January 2016 | October 2018 | October 2018 | November 20, 2015 | November 6, 2017 |
|
|||
30 | NCT02689076 | Recruiting | Regional Data Exchange to Improve Care for Veterans After Non-VA Hospitalization |
|
|
Interventional | Not Applicable |
|
U.S. Fed |
|
|
975 | All | 65 Years and older (Adult, Senior) | NCT02689076 | IIR 14-049 | March 14, 2016 | July 31, 2019 | December 31, 2019 | February 23, 2016 | December 12, 2017 |
|
||
31 | NCT00817375 | Recruiting | Pharmacogenomic Study to Predict Antidepressant Responsiveness in Depressed Patients |
|
|
Interventional | Not Applicable |
|
Other |
|
|
1000 | All | 19 Years to 89 Years (Adult, Senior) | NCT00817375 | 2003-01-12 | February 2003 | December 2018 | December 2018 | January 6, 2009 | December 31, 2015 |
|
||
32 | NCT02936934 | Not yet recruiting | Comparison of Adverse Drug Reactions Associated for Oxycodone and Morphine in Postoperative Pain After Abdominal Hysterectomy |
|
|
Interventional | Phase 4 |
|
Other |
|
|
64 | Female | 30 Years to 55 Years (Adult) | NCT02936934 | HospitalCG | October 2016 | December 2016 | February 2017 | October 18, 2016 | October 18, 2016 | |||
33 | NCT03084952 | Not yet recruiting | Phase 2 Trial to Evaluate 18-Methoxycoronaridine Efficacy, Safety and Tolerability in Cutaneous Leishmaniasis Patients |
|
|
Interventional | Phase 2 |
|
Industry / Other |
|
|
52 | All | 18 Years to 59 Years (Adult) | NCT03084952 | HB/F2-002/2016 | November 2017 | August 2018 | September 2018 | March 21, 2017 | August 18, 2017 | |||
34 | NCT02353455 | Recruiting | Cells of Monocytic Origin as Surrogate Markers for Individual Drug Effects and Hepatotoxicity |
|
|
Observational |
|
Other |
|
|
300 | All | 2 Years and older (Child, Adult, Senior) | NCT02353455 | 055-13 | March 2013 | March 2020 | August 2022 | February 2, 2015 | March 6, 2018 |
|
|||
35 | NCT02559960 | Recruiting | Post-marketing Safety Surveillance of Breviscapine Powder-Injection : a Registry Study |
|
|
Observational |
|
Other |
|
|
20000 | All | Child, Adult, Senior | NCT02559960 | Dengzhan-V1.0 | September 2015 | June 2018 | September 25, 2015 | November 30, 2017 |
|
||||
36 | NCT03135470 | Recruiting | Pain Medication After Ambulatory Surgery |
|
Observational |
|
Other |
|
|
1200 | All | 18 Years and older (Adult, Senior) | NCT03135470 | HUS235/2017 | April 3, 2017 | December 31, 2019 | December 31, 2019 | May 1, 2017 | May 1, 2017 |
|
||||
37 | NCT03051880 | Recruiting | Preventive Effect of EGF Cream for Cutaneous Adverse Event of EGFR Inhibitors |
|
|
Interventional | Not Applicable |
|
Other |
|
|
40 | All | 20 Years and older (Adult, Senior) | NCT03051880 | VC16EISE0180 | November 2016 | December 2017 | December 2018 | February 14, 2017 | February 14, 2017 |
|
||
38 | NCT03047863 | Recruiting | Therapeutic Effect of EGF Cream for Cutaneous Adverse Event of EGFR Inhibitors |
|
|
Interventional | Not Applicable |
|
Other |
|
|
20 | All | 20 Years and older (Adult, Senior) | NCT03047863 | VC16EISI0179 | November 2016 | August 2017 | December 2017 | February 9, 2017 | February 10, 2017 |
|
||
39 | NCT03098680 | Recruiting | A Study of the Pharmacokinetic and Pharmacodynamic Responses in Healthy and Altered Human Cardiovascular Systems |
|
|
Interventional | Phase 1 |
|
Other / Industry |
|
|
32 | Male | 18 Years and older (Adult, Senior) | NCT03098680 | PRIME (A094136) | PRIME | April 24, 2017 | February 29, 2020 | February 29, 2020 | April 4, 2017 | May 3, 2017 |
|
|
40 | NCT02239237 | Recruiting | Post-marketing Safety Surveillance of Compound Kuh-seng Injection: a Registry Study |
|
|
Observational |
|
Other |
|
|
30000 | All | Child, Adult, Senior | NCT02239237 | Kuh-seng1.0 | September 2014 | June 2018 | September 12, 2014 | November 30, 2017 |
|
||||
41 | NCT03125603 | Recruiting | Side Effects of Anti-PD-(L)-1 and Anti CTLA-A4 in the Non Small Cells Lung Cancer |
|
|
Observational |
|
Other |
|
|
140 | All | 20 Years to 85 Years (Adult, Senior) | NCT03125603 | 2017/15MAR/137 | April 13, 2017 | December 31, 2018 | December 31, 2018 | April 24, 2017 | April 24, 2017 |
|
|||
42 | NCT03183908 | Recruiting | FLUAD vs. Fluzone High-Dose Study |
|
|
Interventional | Phase 4 |
|
Other / U.S. Fed |
|
|
900 | All | 65 Years and older (Adult, Senior) | NCT03183908 | Pro00083845 | August 28, 2017 | September 2019 | September 2019 | June 12, 2017 | September 26, 2017 |
|
||
43 | NCT03368391 | Not yet recruiting | : Pulpal Blood Flow With the Use of Intra-nasal Anesthetic |
|
|
Interventional | Phase 4 |
|
Other |
|
|
25 | All | 18 Years to 30 Years (Adult) | NCT03368391 | 9924 | January 3, 2018 | June 30, 2018 | June 30, 2018 | December 11, 2017 | December 11, 2017 | |||
44 | NCT03251144 | Recruiting | Relative Mitochondrial Toxicity of Tenofovir Alafenamide (TAF) vs. Tenofovir Disoproxil Fumarate (TDF) |
|
|
Interventional | Phase 1 Phase 2 |
|
Other / Industry |
|
|
35 | All | 18 Years to 80 Years (Adult, Senior) | NCT03251144 | CO-US-311-4393 | UCLACAREMITO | January 8, 2018 | January 8, 2020 | July 31, 2020 | August 16, 2017 | August 16, 2017 |
|
|
45 | NCT02738047 | Recruiting | Reduction of Adverse Drug Events and Readmissions |
|
Observational |
|
Industry |
|
|
280000 | All | 25 Years and older (Adult, Senior) | NCT02738047 | 10202016 | RADAR-PGX | March 2016 | March 2019 | June 2019 | April 14, 2016 | May 19, 2017 |
|
|||
46 | NCT03211208 | Recruiting | Assessing Antibiotic Induced Liver Injury for Stratification of Tuberculosis Patients |
|
Observational |
|
Other |
|
|
540 | All | 16 Years to 85 Years (Child, Adult, Senior) | NCT03211208 | AC16145 | ALISTER | May 22, 2017 | April 2020 | April 2020 | July 7, 2017 | July 7, 2017 |
|
|||
47 | NCT03071133 | Recruiting | Real-world Incidence Proportion of Hepatic Toxicity and All Adverse Drug Reactions (ADRs) in Japanese Patients Receiving Daclatasvir (DCV) Trio Therapy |
|
Observational |
|
Industry |
|
|
1000 | All | Child, Adult, Senior | NCT03071133 | AI443-144 | February 27, 2017 | November 20, 2019 | November 20, 2019 | March 6, 2017 | December 13, 2017 |
|
||||
48 | NCT03451734 | Recruiting | Individualized Optimal Therapy of Antipsychotics |
|
|
Observational |
|
Other |
|
|
3600 | All | 17 Years to 65 Years (Child, Adult) | NCT03451734 | 2016YFC1306900 | December 9, 2016 | October 1, 2018 | December 31, 2020 | March 2, 2018 | March 2, 2018 |
|
|||
49 | NCT03338725 | Recruiting | Effect and Associated Factors of the Clinical Pharmacy Model in the Incidence of Medical Errors |
|
|
Interventional | Not Applicable |
|
Other |
|
|
720 | All | Child, Adult, Senior | NCT03338725 | 0016052017JG | EACPharModel | February 1, 2018 | January 30, 2019 | November 1, 2019 | November 9, 2017 | February 9, 2018 |
|
|
50 | NCT03501108 | Recruiting New |
Discontinuation of Long-term Medications in Older People Entering Nursing Home Care |
|
|
Interventional | Not Applicable |
|
Other |
|
|
160 | All | 75 Years and older (Senior) | NCT03501108 | 1767 | STOPPFrail | March 27, 2018 | June 30, 2019 | June 30, 2019 | April 17, 2018 | April 17, 2018 |
|
† Study has passed its completion date and status has not been verified in more than two years.